Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,022 | -4,162 | -1,031,559 | -1,029,814 | -1,043,764 |
| Depreciation Amortization | 1,019 | 513 | 1,575 | 1,063 | 556 |
| Income taxes - deferred | 19,305 | 6,050 | 72,637 | 41,316 | 27,060 |
| Accounts receivable | 71,015 | 57,107 | 924 | 5,501 | 11,057 |
| Other Working Capital | 44,221 | 33,199 | 11,279 | 19,824 | 24,570 |
| Other Operating Activity | -52,088 | -47,722 | 1,128,571 | 1,109,703 | 1,095,655 |
| Operating Cash Flow | $78,450 | $44,985 | $183,427 | $147,593 | $115,134 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -126 | -68 | -273 | -62 | -13 |
| Net Acquisitions | N/A | N/A | -1,026,045 | -1,022,068 | -999,492 |
| Investing Cash Flow | $-126 | $-68 | $-1,026,318 | $-1,022,130 | $-999,505 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150,000 | N/A | 400,000 | 400,000 | 400,000 |
| Debt Repayment | -225,000 | -25,000 | -100,000 | -75,000 | N/A |
| Common Stock Issued | 10,810 | 10,061 | 6,357 | 5,359 | 5,347 |
| Common Stock Repurchased | N/A | N/A | -26,311 | N/A | N/A |
| Other Financing Activity | -737 | -616 | -2,886 | -2,295 | -2,295 |
| Financing Cash Flow | $-64,927 | $-15,555 | $277,160 | $328,064 | $403,052 |
| Exchange Rate Effect | -27 | 24 | -53 | -3 | N/A |
| Beginning Cash Position | 92,154 | 92,154 | 657,938 | 657,938 | 657,938 |
| End Cash Position | 105,524 | 121,540 | 92,154 | 111,462 | 176,619 |
| Net Cash Flow | $13,370 | $29,386 | $-565,784 | $-546,476 | $-481,319 |
| Free Cash Flow | |||||
| Operating Cash Flow | 78,450 | 44,985 | 183,427 | 147,593 | 115,134 |
| Capital Expenditure | -126 | -68 | -273 | -62 | -13 |
| Free Cash Flow | 78,324 | 44,917 | 183,154 | 147,531 | 115,121 |